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INTRODUCTION  
 According to the American Cancer Society one in three Americans will be 
diagnosed with cancer in their lifetime. Research is conducted in order to enhance the 
efficacy and reduce the side effects of treatments. Despite laborious works, treatments 
such as radiotherapy still pose significant side effects and decrease quality of life for 
patients. Therefore, our lab aims to sensitize medulloblastoma and colorectal cancer 
cells to chemotherapy drug by targeting Dicer. With the same amount of drug, the 
chemosensitized cancer cells will die at a faster rate. This strategy can potentially 
eliminate treatments that cause significant side effects to patients.  
 
Human Dicer is a large multi domain protein about 200,000 Daltons in size.1 
There are two main functions of Dicer. First it generates short non-coding siRNAs 
and miRNAs, secondly it recruits DNA damage response (DDR) factors. The 
recruitment of DDR proteins by Dicer allow cells to undergo DNA repair. The 
purpose of generating non-coding siRNAs and miRNAs is to regulate post-
transcriptional gene silencing.2 Specifically, Dicer cleaves the precursor RNAs and 
loads them to the Argonaute protein. Then the siRNA or miRNA Argonaute complex 
binds to the complementary mRNA and suppress its translation.  
Fascinatingly, the dsRNA cleavage mechanism was also discovered in plant 
cells as a defense mechanism to viral infection. The viral dsRNAs are cleaved by 
Dicer and are loaded to argonaute protein complex. The viral RNA fragment plus 
argonaute complex complimentarily bind to viral transcripts. This process inhibits 
translation of viral particles and suppresses its proliferation. Since this mechanism 
was recognized in plants, investigation is underway to discover a conserved 
mechanism in mammalian cells.  
The cleavage of the dsRNA and pre-micro RNA occurs in the Dicer’s catalytic 
site that contains two intermolecular RNase IIIb dimers. Other domains present in the 
protein such as the RNA Binding domain, dsRNA Binding Domain, and PAZ also 
assist in the RNA cleavage.3 Several Mg+2 ions are additionally present in the 
catalytic site to neutralize the charge repulsion and increase the binding affinity to the 
RNAs.  
 
Medulloblastoma (MB) is the most common brain tumor in children and 
treatment consists of surgery, chemotherapy, and radiotherapy.4 Unfortunately, due to 
radiotherapy’s substantial side effects such as endocrine abnormalities and long-term 
neurocognitive deficits, it is delayed or even avoided for patients less than 3 years of 
age.5 One strategy to decrease radiotherapy treatment for MB patients would be to 
increase the efficacy of existing chemotherapy drugs. Interestingly, collaborative 
works of our lab and others have identified that full loss of the Dicer gene increased 
DNA damage in a mouse model, figure 1. Moreover, when the Dicer knockout (KO) 
cells were treated with etoposide, a commonly used chemotherapy, cell death of 
medulloblastoma increased substantially compared wild-type cells, figure 2. These 





Figure 1. Cross section of mouse cerebellum, the gH2Ax immunostain indicates DNA damage in cells. 
Higher DNA damage, orange stain, is seen in Dicer knockout compared to wild-type cells. Image 
adopted from Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing Cells of 




Figure 2. Etoposide injection to Dicer KO versus wildtype mouse medulloblastoma. The cC3 indicates 
the caspase 3, a protein that gets activated during cell death. Highest cell death was identified with 
Dicer KO injected with etoposide. The wild-type cells injected with etoposide shows minor cell death. 
Image adopted from Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing 
Cells of the Developing and Malignant Cerebellum 
  
 
Interestingly chemosensitivity in Dicer knockout was also discovered in 
colorectal cancer cells.6 Therefore, our lab also focuses on chemosensitizing 
colorectal cancers using Dicer KO. Colorectal cancer is the “third most common 
cancer in men and second in women worldwide.”7 Biologically, colorectal carcinoma 
(HCT116) is sustained by a subpopulation of cancer-initiating cells (CICs) also 
referred to as cancer stem cells.8 The CICs are thought to play a significant part in 
A3. The role of Dicer in DNA repair.  While the primary role of Dicer is in the miRNA biogenesis pathway 
there have been several miRNA-independent functions that have been ascribed to it35,36.  or e ample, several 
studies have demonstrated that Dicer deficient cells have defects in DNA damage response pathways37.  In 
some cases, the effect is mediated though depletion of specific miRNAs that regulate DNA repair pathways38,39. 
owever, several recent papers have proposed an alternative model that is independent of miRNAs40-42.  
pecifically, small RNAs have been identified that originate from DNA double strand breaks.  hese RNAs, 
which are Dicer dependent, are proposed to direct the DNA repair pathway to the source of the breaks43.  
Interestingly, Dicer has also been shown to interact with RNA polymerase II44.  This interaction has been shown 
to facilitate release of stalled polymerase from DNA breaks and allow more efficient repair.  he RNAi effector 
protein Ago2 has also been shown promote repair of breaks through Rad51 interaction45.  The mechanistic 
details of these various pathways are not fully understood but it raises the possibility that phenotypes observed 
in tissue specific Dicer knockouts are not solely due to miRNA depletion but are also the result of a defect in 
DNA damage response pathways.
We were interested in analy ing the role of Dicer in maintaining genomic integrity in the developing mouse 
brain5.  Using a ath1- re driver we deleted Dicer in cerebellar granule neuron precursors N  shortly 
after birth.  Dicer loss led to degeneration of cerebellar neurons and animals displayed movement defects and 
a shortened lifespan.  When we e amined the cause of neuronal degeneration we observed an increase in 
DNA damage induced apoptotic cell death igure .  N s are rapidly proliferating at postnatal days  to 
8 and are known to be subjected to high levels of replicative stress.  The loss of Dicer prevents the repair of 
stress induced breaks and results in cell death.  At later developmental time points cerebellar neurons become 
post-mitotic and are no as longer sensitive to DNA damage.  his correlates with low levels of Dicer e pression 
igure .
A4. Dicer deletion sensitizes MB cells to chemotherapy  To directly test the requirement for Dicer in cancer 
cells we deleted Dicer in a mouse model for MB5. his model is based on e pression of constitutively active 
allele of moothened mo 2  that results in activation of the onic edgehog signaling pathway.  hese 
animals develop aggressive tumors in the cerebellum starting around postnatal day 20. When Dicer was 
deleted in these cells the tumors were markedly smaller with increasing levels of DNA damage and apoptosis 
igure .  reatment of the animals with the chemotherapeutic etoposide significantly increased DNA damage 
and cell death igure , Right .  nterestingly, Dicer depletion has also been shown to induce chemosensitivity 
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Figure 4.  Dicer expression in medulloblastoma.  Dicer e pression 
is elevated in tumors in a mouse model of medulloblastoma.  Tumors 
and wildtype cerebellum were immunoblotted (LEFT) or immunos-
tained (RIGHT) at the indicated postnatal time point.  Dicer protein 
appears brown in immunostained samples.
Figure 5.  DNA da ag  in Dicer null cerebellum.  DNA damage markers 
increase in Dicer knockout cerebellum.  Dicer was deleted in postnatal cerebel-
lum with a Math1-Cre driver.  DNA damage was measured by immunostaining 
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Figure 3. Dicer expression in brain. Dicer 
e pression decreases during postnatal develop-
ment.  orte  and cerebellum protein from post-
natal days 2, 40, and 150 was immunoblotted for 
Dicer, Drosha, and Argonaute2.  Tubulin is shown 
as a loading control.   
As stated above, Dicer has been 
linked to the DNA damage response 
in miRNA dependent and independent 
pathways.  At this point it is unclear 
which mechanism is predominant in 
the proliferating neonatal cerebellum 
and in B.  or the purposes of this 
proposed project, however, either 
mechanism supports our overarching 
hypothesis:  Complete loss of Dicer 
in medulloblastoma cells impairs the 
DNA damage response pathway and 
confers sensitivity to DNA damaging 


























































































































Figure 4. Dicer Deletion Leads to Reduced Tumor Volume in the SmoM2 Mouse Model of Medulloblastoma
(A) H&E analysis of P20 WT (WT SmoM2) and Dicer-deleted medulloblastoma (KO SmoM2).
(B) Quantification of tumor load in (A).
(C and D) Phospho-histone H3 (pH3) staining of P4 WT SmoM2 and Dicer KO SmoM2 (C); quantification of pH3-positive cells is shown in (D).
(E and F) gH2AX staining of P4 WT SmoM2 and Dicer KO SmoM2 (E); quantification of gH2AX-positive cells is shown in (F).
(G and H) Cleaved caspase-3 (cC3) staining of P4 WT SmoM2 and Dicer KO SmoM2 (G); quantification of cC3-positive cells is shown in (H).
(I) Immunohistochemical staining for cC3 in P18 WT and Dicer KO SmoM2 mice that were injected with etoposide (5 mg/kg). Uninjected mice were used as
controls.
(J) Quantification of cC3-positive cells shown in (I).
Scale bars, 500 mm (A) or 300 mm (C, E, and G). *p < 0.05, **p < 0.01 (two-tailed, unpaired Student’s t test). Error bars, means ± SEM.
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tumor relapse and patient survival.9 Thus, decreasing CICs proliferation can decrease 
tumor relapse and increase patient survival.  
Recent findings have shown that epigenetic therapy such as 5-aza-2-
deoxycytidine (5-AZA-CdR) can be used to target and decrease CIC proliferation 
rate. The drug, 5-AZA-CdR, increases transcription of endogenous retroviral 
transcripts. Presence of viral transcripts initiates a viral signal pathway (MDA5/ 
MAVS/IRF7) activates interferon, a protein that gets released when cells are infected 
with pathogens. Fascinatingly, this viral signal pathway decreases CICs 
proliferation.10.  
Also, upon presence of viral transcripts, the body can potentially utilize RNA 
interference (RNAi) pathway as defense mechanism. As mentioned before, the viral 
dsRNA may be recognized and cut by Dicer into short fragments called siRNAs or 
also known as viRNAS. These fragments can be loaded onto Argonaute protein and 





 Using the evidence that Dicer KO increases chemosensitivity, our lab aims to 
find small molecule that will inhibit Dicer. By inhibiting Dicer in medulloblastoma 
and colorectal cells this will increase chemosensitivity and cell death. Higher cell 
death in chemosensitized cells can potentially remove therapies that pose significant 
side effects to patients.   
Moreover, demethylating agent 5-AZA-CdR has shown to decrease CICs 
proliferation by inducing the expression of endogenous viral transcripts. It is still 
unclear if Dicer uses the viral-RNA based immune response pathway. But if it does, 
Dicer inhibition can obliterate the viral-RNA based immune pathway and increase 
endogenous retroviral expression. Higher viral load in Dicer KO cells can further 
decrease the CICs proliferation rate which in turn decreases colorectal relapse and 
increase patient survival.  
 
MATERIALS AND METHODS  
Dicer siRNA Transfection 
 Lupus Erythromatosus (LE) and Daoy medulloblastoma cell lines where 
transfected with Dicer inhibiting siRNA. The siRNA was introduced using 
Lipofectamine TM 2000 transfection reagent. For LE cells transfection was conducted 
around 50% cell confluency with 20 pmol of siRNA. Before the transfection, the cell 
medium was changed to Opti-MEM. Then Lipofectamine TM 2000 was diluted to 1: 
50 ratio with Opti-MEM and was incubated for 5 minutes at room temperature. After 
incubation 20 pmol siRNA was combined with diluted Lipofectamine and was 
incubated again for 20 minutes. Then the appropriate volume of transfection reagents 
was added to each well. After 6 hours, Lipfectamine and Opti-MEM was replaced 
with Dulbecco Modified Eagle Medium  (DMEM) in 10% FBS and 1% penicillin. 
After 2 days of incubation in DMEM differing concentration of etoposide was added. 
Subsequently, the 2-day drug treated cells were stained with crystal violet to visualize 
cell viability. For DAOY cells transfection occurs around approximately 80% cell 
confluency and 20 pmol of siRNA was used. The same transfection protocol was 
followed as written above. After 6 hours of transfection, the cells’ medium was 
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changed to DMEM. Cells were exposed to differing etoposide concentration for three 




The Sf9 insect cells were grown in a spinner flask with a magnetic stir bar at 
28 oC in Grace medium (Thermo Fisher) with 10% fetal calf serum and 1% penicillin. 
Approximately 1.0 L Sf9 cells at concentration of 1 x106 cell/ mL were infected with 
recombinant baculovirus with the multiplicity of infection of 1.0. After 72 hours of 
incubation cells were centrifuged (1,000g, 10 minutes) and resuspended with 200 mL 
of PBS. Cells were washed with 20 mL of W100 Buffer (Tris-HCL, pH 7.5, 100 mM 
NaCl, 1 mM MgCl2, 5 mM betamercaptoethanol, 10 % glycerol, and 0.5 % Triton X-
100) and one tablet of 1xEDTA-free protease mix inhibitor. The cells were passage 
through 2.3 gauge 5 times and was centrifuged again at 12,000g for 1 hour at 4oC. 
The supernatants were collected and used for protein purification. Prewashed with 
W100 buffer, the TalonTM resin and the supernatants were placed into a conical tube. 
The tube was placed onto a rotor for 20 minutes.  Then the resin and cell mixture was 
placed onto a column and was washed 3 times in the order of W100, W800 (800 mM 
NaCl), and W100 8. Then ten tubes containing different Imidazole concentrations in 
W100 buffer (30 mM, 60 mM, 90 mM, 120 mM, 150 mM, 180 mM, 210 mM, 240 
mM, 270 mM, 300 mM) were used to elute off the Dicer protein. Fractions were 
loaded onto 6% polyacrylamide gel and stained with Coomassie brilliant blue. 
Fractions that contained the Dicer were collected. Then to the prewashed Sepharose 
(GE Health and Life Sciences) beads imidazole eluted fractions containing Dicer were 
loaded. A gradient elution with differing NaCl concentrations (20 tubes with 0.05 M 
NaCl increase at 0.5 mL volume) was conducted. The 20 fractions were loaded onto 
6% polyacrylamide gel and stained with Coomassie brilliant blue to detect total 
protein concentration. The fractions that contained purest concentration of Dicer (E2, 
E3) were collected, figure3. Western blot was conducted, figure 4, to further confirm 
the presence of Dicer protein. After the purification, Dicer concentration was 
determined using Q bitTM fluorometric quantitation.  
 
 
Figure 3. Purification of Dicer resolved in 6% polyacrylamide gel stained with Coomassie brilliant 
blue. The blue arrow on top indicates the presence of Dicer in E1, E2, and E3 lanes. 
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Figure 4. The Western blotting of recombinant Dicer stained with mouse monoclonal anti-His-tag 
antibody horseradish peroxidase. The top broad band at 230kDa is Dicer. Other smaller fragments are 
speculated to be degraded fragments of the Dicer protein.  
 
High-throughput Screening (HTS): Dicer Inhibitors 
To determine the Dicer’s cleavage efficiency a fluorescence-based assay was 
used. First, the two RNA strands were annealed. One of the strands contained a 
fluorescent group (Cy5) whereas the other strand contained the quencher. When Dicer 
cleaved the dsRNA, the fluorescent group was released. The free-floating fluorescent 
Cy5 absorbed 640 nm and emitted 670 nm electromagnetic waves. Thus, Dicer’s 
cleavage activity was correlated with fluorescence intensity, Figure 5. The schematic 
nucleotide sequence for the quencher and the fluorescent strand is outline in figure 6.  
 
 
Figure 5 Image adopted from Fluorescence-Based High-Throughput Screening of Dicer Cleavage 
Activity 7, this image represents the relationship between fluorescence and Dicer cleavage activity. 
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over conditions, presumably through stabilization of Dicer-
substrate complexes.10
A highly efficient, low-cost, safe, and robust assay is a 
prerequisite for successful high-throughput screening 
(HTS). Until now, several assays for monitoring Dicer 
activity in vitro were developed.12–14 In vitro cleavage 
assays employed different Dicer substrates, such as perfect 
RNA duplexes of various lengths (30–150 bp) with or with-
out 3′ overhangs9,13,14 or substrates mimicking pre-miRNA 
structure.12 Cleavage assays have typically been based on 
processing of radiolabeled dsRNA substrates by recombi-
nant Dicer and detection of cleaved products by electropho-
resis.9,14 However, this type of assay is not suitable for HTS. 
A conceivable solution is an assay yielding fluorescence 
upon cleavage by Dicer12,13 where cleavage of a substrate 
carrying fluorescent and quencher groups in close proxim-
ity results in separation of a fluorophore and a quencher.
Here, we present development and use of a fluorescent 
cleavage Dicer assay for screening chemical compound 
libraries. This assay has been validated in HTS in terms of 
its affordability, safety, robustness, adaptability to low vol-
umes, and suitability for automation using a library of 2816 
small bioactive compounds.
Materials and Methods
Protein Expression and Purification
pDEST-Dicer-HisC vector for expression of C-terminally 
His6-tagged human Dicer was kindly provided by Witold 
Filipowicz.14 Bacmids for insect cell transformation and 
recombinant virus expressing tagged human Dicer for insect 
cell infection were generated according to Bac-to-Bac 
Baculovirus Expression System (Invitrogen, Carlsbad, CA) 
manufacturer’s recommendations. Approximately 2 × 109 
Sf9 insect cells were infected with recombinant baculovirus 
(multiplicity of infection ~1.0). Cells were grown at 28 °C in 
TNM-FH insect medium supplemented with 10% fetal calf 
serum (Invitrogen), penicillin (100 U/mL; Invitrogen), strep-
tomycin (100 mg/mL; Invitrogen), and 0.1% Pluronic 
(Sigma-Aldrich, St. Louis, MO) and harvested 72 h after 
infection. Cells were gently pelleted by centrifugation and 
divided into eight batches, which were consecutively pro-
cessed as follows: cells were resuspended in 20 mL of ice-
cold binding buffer (20 mM Tris-HCl [pH 7.5], 100 mM 
NaCl, 1 mM MgCl
2
, 10% glycerol, 0.5% Triton X-100, 
EDTA-free protease inhibitor mixture [Roche, Basel, 
Figure 1. Fluorescent in vitro Dicer cleavage assay: (A) Scheme of domain order in human Dicer protein. HEL, helicase domains; 
PAZ, piwi/argonaute/zwille domain; dsRBD, double-stranded RNA binding domain. (B) A scheme of structural organization of 
human Dicer and interaction with a pre-microRNA substrate. The scheme is based on available structural data.3,21 Red “pacmen” 
indicate active sites of RNase III domains, each of which cleaves one strand of the substrate. (C) Dicer substrate for fluorescent 
cleavage assays. One end contains a 3′ two-nucleotide overhang, which binds with a high affinity the PAZ domain of the Dicer. The 
other end of the substrate is blunt and carries a fluorescent group at the 5′ end of one RNA strand and a quencher group at the 
3′ end of the other strand. (D) The principle of the assay. Fluorescent and quencher group in uncleaved substrate remain in close 
proximity under assay temperature (37 °C). Dicer binds with high affinity the 3′ two-nucleotide overhang and cleaves the substrate, 
producing a short duplex with fluorescent and quencher groups. This short duplex is thermodynamically unstable, resulting in the 
separation of fluorescent and quencher groups and an increase of fluorescence. Red “pacmen” indicate active sites of RNase III 
domains. (E) Recombinant Dicer used for the cleavage assay. The left gel image shows Coomassie brilliant blue R-250 staining of 
a 6% polyacrylamide gel, in which indicated amounts (in microliters) of purified Dicer were resolved. The right gel image shows 
Western blotting of 1 and 5 µL of recombinant Dicer stained by mouse monoclonal anti–His-tag antibody conjugated with horseradish 
peroxidase. Positions of size marker bands in kDa are indicated on the left side of each gel image. Arrows mark the C-terminally 
tagged recombinant human Dicer purified from insect cells.
 at University of North Carolina at Chapel Hill on December 4, 2016jbx.sagepub.comDownloaded from 
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Figure 6. Image adopted from Continuous fluorescence-based method for assessing Dicer cleavage 
efficiency reveals 3' overhang nucleotide preference 7, shows the nucleotide sequence for the Cy5 and 
quencher strand used for experimental fluorescence assay.  
 
The Dicer assay was carried out with the appropriate buffer (30 mM Tris-HCl 
[pH 80], 50 nM NaCl, 3 mM MgCl2, 0.25% Triton-X100, and 15% glycerol) in 
corning 96 Flat Bottom black, clear bottom Polystyrol. The assay also contained ATP, 
deionized water, and differing concentration of Dicer (45 nM, 454 nM) and substrate 
(500 nM, 50 nM, 5 nM, 0.5 nM) to reach a final volume of 25 𝜇L. Also, positive 
control (Cy5 strand only) and negative control (EDTA) was used to determine the 
maximum and the minimum fluorescence. Tecan i-control reader system was used to 
measure fluorescence. Instrumental setting used in experiment is outlined in Table 1. 
Then 1593 small molecules from National Cancer Institute (NCI) diversity set V were 
introduced to the assay and Dicer activity was measured.  
 
Table 1. Below shows the setting used in Tecan i-control to measure fluorescence in 
Corning 96 plate.  
Target Temperature 37 °C 
Kinetic Cycles Different for each experiment 
Interval Time 0:05:00 min 
Excitation Wavelength 640 nm 
Emission Wavelength 670 nm 
Excitation Bandwidth 5 nm 
Emission Bandwidth 15 nm 
Gain Optimal 
Number of Flashes 100 
Flash Frequency 400 
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randomly selected D-siRNA substrates 
from human cDNA were screened using 
a f luorogenic Dicer substrate in heterol-
ogous competition assays to investigate 
the effect of 3b overhang sequence in the 
cleavage efficiency of Dicer.
Materials and methods
R NA and expression/purification 
of protein constructs
Human Dicer was expressed in an insect 
baculovirus system using the titerless 
infected-cells preservation and scale-up 
method (13,14). Baculoviruses were 
generated using the Bac-to-Bac system 
(Invitrogen, Carlsbad, CA, USA). Dicer 
was engineered into pFastBac to express 
the full length protein with an N-terminal 
6xHis-tag, and a TEV protease site was 
inserted between the open reading frame 
and His-tag for purification purposes. 
Dicer was purified using a three-step 
purification method: nickel affinity, 
reverse nickel affinity, and size-exclusion 
chromatography. Brief ly, 1 L cells was 
suspended in 100 mL lysis buffer (buffer 
NA) composed of 50 mM Tris pH 8.0, 
500 mM NaCl, 5% glycerol, 0.1% Triton 
X-100, 5 mM TCEP, and protease inhib-
itors. The cells were lysed with a micro-
f luidizer (Watts Fluidair, Richland, 
MI, USA). Cell debris was sedimented 
by centrifugation at 40,000× g for 2 h 
at 4°C. The supernatant was filtered 
and loaded with 5 mM imidazole onto 
a HisTrap HP column (GE Healthcare, 
Piscataway, NJ, USA) equilibrated with 
0.5% buffer NB (buffer NA containing 
1M imidazole). The column was step-
washed/eluted with 0.5% to 2.5%, 2.5% 
to 5–10%, and 5–10% to 30% buffer 
NB. The fractions containing Dicer 
were pooled and TEV protease was 
added (50 units/mg protein), followed 
by dialysis against Buffer NA overnight 
at 4°C to remove the His-tag. The 
dialyzed proteins were then applied to 
a HisTrap HP column (GE Healthcare) 
and the unbound proteins were pooled 
and concentrated to 3 mL. Samples 
were further purified through a size-
exclusion column Superdex200 16/60 
(GE Healthcare Biosciences, Piscataway 
NJ, USA) equilibrated with gel filtration 
buffer (50 mM Tris pH 8.0, 300 mM 
NaCl, 0.5 mM EDTA, 10% glycerol, 
and 2 mM DTT) with a 1 mL/min 
f low rate. Fractions containing Dicer 
were pooled and concentrated. Protein 
concentrations were measured using 
the Bio-Rad Bradford assay (Cat. no. 
500–0002; Hercules, CA, USA) with 
BSA as a standard. Proteins were f lash-
frozen in liquid nitrogen and stored at 
-80°C. Labeled D-siRNA molecules 
were purchased from Integrated DNA 
Technologies (IDT, Coralville IA, USA) 
and purified by RNase-free high-pressure 
liquid chromatography (HPLC). All 
preparations of Dicer enzyme were tested 
for the presence of single-strand RNase 
activity with the RNase-Alert QC system 
(Cat. no. AM1966; Ambion, Austin, 
TX, USA) (Supplementary Figure 1). Gel 
electrophoresis analysis of Dicer cleavage 
products of 28-mer substrate confirmed 
a product size of ~21 bp.
Steady-state enzyme kinetics
Determination of kcat and Km values 
for the f luorescent Dicer substrate was 
performed by titration of 20 nM Dicer 
with increasing concentrations of labeled 
substrate (0.006–1 μM) in Corning 
half-area 96-well plates (Cat. no. 3642; 
Lowell, MA, USA). Fluorescent RNA 
was prepared by dilution of 100 μM 
stock Cy5 and Iowa Black RQ–labeled 
RNA strands (Iowa Black RQ; IDT, 
Coralville IA, USA) in Dicer reaction 
buffer [100 mM Bis-Tris propane (Sigma-
Aldrich, St. Louis, MO, USA) pH 9.0, 
150 mM NaCl, and 2 mM MgCl2]. This 
Figure 1. Fluorescent Dicer substrate design. (A) Scheme for design of fluorescent Dicer substrate. 
The substrate is modified on th  5b and 3b ends with Cy5 and Iowa Black RQ (IowaBlkRQ) fluores-
cence quencher, respectively. Upon cleavage by Dicer, the resulting “cap” fragment has a Tm lower 
than the assay temperature of 30°C. (B) Titration experiment with sequences indicated in panel A. 
A sample of Cy5-labeled guide strand (0.971 μM) is titrated with quencher-labeled passenger strand 
(green circles). After addition of quencher strand to 1.75:1 molar ratio, Dicer is added (484 nM); 
subsequent incubation for 6 h at 30°C leads to partial recovery of 66% of fluorescence intensity 
compared with Cy5-labeled guide strand alone (blue data point). Recovery of the fluorescence signal 
is not 100% due to the presence of excess quencher in solution. (C) Reaction velocity for the cleavage 
of the labeled substrate sequence in panel A (expressed as the change in substrate concentration in 





Inducing Endogenous Viral Transcripts  
 Human colorectal HCT116 cells were plated 24 hours in DMEM (10% FBS 
and 1% penicillin) media prior to drug treatment. Around 30% cell confluency, cells 
were treated with 5-AZA-CdR. Depending on the experiment different concentration 
(300 nM, 900 nM, 1200 nM) and length (1 day, 5 day) of 5-AZA-CdR was 
introduced. Cells were washed with DMEM before replenishing with fresh media. 
Selected plates exposed to 300 nM of 5-AZA-CdR were also introduced with either 
celastrol (30 µM) or Redoxol (100 µM). Cell viability of was measured after one 
week of drug exposure. Also, total RNA were extracted for selected cells and reverse-
transcriptase PCR was conducted.  
 
RESULTS 
Dicer siRNA Transfection 
 The medulloblastoma cell line Daoy was transfected with Dicer siRNA. Then 
the knockout and the wild type were exposed to differing etoposide concentration for 
approximately 60 hours. Then the cells were stained with violent blue dye to visualize 
the cell viability. As shown below in figure 7, Daoy cells transfected with Dicer 
siRNA had significant cell death compared to wild type. The difference of cell 
viability was prominent at lower etoposide dose.  
 
Figure 7. DAOY cell, wild type (no siRNA inhibition) or Dicer knockout ( siRNA inhibition), were 
injected with differing concentration of etoposide. Dicer knockout cells increased chemosensitivity 
compare to wild type, and cell viability noticeably decreased for KO from 100 nM to 1 nM etoposide.  
Drug Dosage 
The medulloblastoma cell lines (Daoy, D283) were used to investigate the 
optimal dose of etoposide and cisplatin chemotherapy drugs. Differing concentrations 
of the two drugs (100 𝜇M, 30 𝜇M, 10𝜇M, 3 𝜇M, 1 𝜇M, control) were plated into 24-
welled plate. After 72 hours of incubation, the viable cells were counted. Figure 8 and 
9 shows the cells viability after 12 hours of drug exposure. The dosage curve 
conducted for Daoy and D283 cells indicated that dosage over 3	𝜇M of both cisplatin 




Figure 8. From left to right, D 283 control, D283 with 100 𝜇M etoposide, D283 with 100 𝜇M of 
cisplatin. Even after 12 hours of incubation, cell viability is decreased.  
 
Figure 9. From left to right, DAOY control, DAOY with 100 𝜇M etoposide, DAOY with 100 𝜇M of 
cisplatin.  
 
Protein Purification  
Diverse purification techniques were optimized to obtain more purified Dicer. 
Specifically, gradient elution with differing concentrations of NaCl and Imidazole 
was used. However, the 6% polyacrylamide gel analyses showed that other protein 
fragments were also present in the purified protein solution. Around the 230 kDa 
regions a smear of bands was found which indicated that other macromolecules were 
also present in the solution, figure 3 and 4. Utilizing the Methods in Enzymology8, 
overnight dialysis in W100 buffer yielded a purer Dicer.  
 
High-throughput Screening (HTS): Dicer Inhibitors 
A preliminary experiment was conducted using RNAse and EDTA as positive 
and negative control, respectively. Ethylenediaminetetraacetic acid (EDTA) was used 
as negative control since this chelating agent interferes with the Mg+2 in the cleavage 
site and prevents the dsRNA strand to bind. Concentration of 454 nm for Dicer and 60 
nm of RNA substrate was determined as an optimum concentration.  
 A small molecule called kanamycin was tested to investigate its effect on 
Dicer cleavage activity. Experimental results indicated that kanamycin does decrease 
the Dicer activity. However, it was determined that the IC50 was too high to be 




Figure 10. Differing concentration of kanamycin and its affect in Dicer RNA cleavage activity. Data 
collected at 3-hour exposure point.  
 
Furthermore, assay of 1,593 compounds obtained from National Cancer 
Institute (NCI) diversity set V was conducted. The compounds were diluted 40 folds 
in dimethyl sulfoxide (DMSO). Before introducing the inhibitors, DMSO was tested 
to establish its impact on the fluorescent reading. Experimental data showed that 
DMSO does not interfere with the assay reading, figure 11. The result of all the 1,593 
compounds are shown in figure 13. Compounds below the Z=4 were experimented 
again, figure 14. From the 29 compounds below z=4 line, six potential Dicer 
inhibitors compounds were discovered Figure 12. 
 
 
Figure 101 Different percentages of DMSO was introduced to the assay. Results showed that differing 












































Figure 12. Six compounds experimentally found to inhibit Dicer function. Data provided by Kyle 
Kaufmann.  
 
Figure 13. HTS results of 1,593 small molecule NCI diversity set V. Baseline was measured with 
DMSO well. The Z indicates standard deviation below the mean. Results showed significant decrease 
in Dicer activity for points below Z=4. Data provided by Kyle Kaufmann. 
 
 
Figure 14. The 29 compounds found below the z=4 in diversity set experiment were retested. Most of 
the compounds showed significant decrease in Dicer activity. DMSO was used as baseline.  
	 11	
Inducing endogenous viral transcripts  
Diverse 5-AZA-CdR treatment was conducted to optimize viral transcript induction. 
It was discovered that 24 hours of 300 nM 5-AZA-CdR treatment produced the 
highest viral transcripts. The RT-PCR results showed significant increase in viral 
transcripts for 24-hour 300 nM 5-AZA-CdR treatment in HCT116 cells compared to 
control Figure 15.  
 
 
Figure 15. Relative expression of viral genes. Each transcript level was normalized by the acidic 





Six novel Dicer inhibitors were discovered from experimental HTS assay, 
figure 12. When the inhibitor putpurogallin (5C3) was directly introduced to MB or 
HCT116 cells the chemosensitivity did not change. Several factors such as 
hydrophilicity of the compound and interaction with diverse cellular components 
could have prevented the Dicer inhibition. However, when celestrol (3E6) and redoxal 
(2J11) were introduced to HCT-116, cell viability markedly reduced. Specifically, 
celastrol at 30 µM and redoxol at 100	µM decreased HCT-116 cell viability to 50% 
compared to control. Moreover, HCT-116 exposed to both 5-AZA-CdR (0.3 µM) and 
celastrol (30 µM) showed even higher cell death. Our lab is currently using 
NextGeneration sequencing to determine if this result was due to Dicer inhibition. In 
conclusion, not all, but some of the small molecules identified in the HTS assay 
showed increased cell death in colorectal cells (HCT-116).  
 
Figure 10. Differing concentration of kanamycin and its affect in Dicer RNA cleavage 
activity. Data collected at 3 hour exposure point.  
 
 
Figure 11. Relative expression of viral genes. Each transcript level was norm lized by 
















































Conclusion/ Future steps 
 
Our prospective plan is to introduce the small molecules into animal model 
and determine its impacts. Moreover, we will be screening 100,000 compound 
diversity set in collaboration with UNC Center for Integrated Chemical Biology and 
Drug Discovery department.  
 Our lab focuses on oncological research particularly on medulloblastoma and 
colorectal carcinoma. Comprehensively we utilize Dicer inhibition as a potential 
targeted therapy. Our data indicate that small molecules discovered from HTS assay 
have promising outcome in increasing cell death for both colorectal and 
medulloblastoma cells. By utilizing these small molecules, we can decrease or 
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